HCW Biologics Inc.
HCWB
$4.13
-$0.115-2.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.58% | 68.42% | 20.98% | -254.99% | -47.28% |
| Total Depreciation and Amortization | 72.07% | 148.54% | -53.73% | -54.31% | -18.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.21% | -94.70% | 30.12% | 57.87% | 66.30% |
| Change in Net Operating Assets | -164.02% | -143.60% | 155.56% | 281.91% | 242.19% |
| Cash from Operations | 2.50% | 27.21% | 47.64% | 48.23% | 0.94% |
| Capital Expenditure | -- | 96.95% | 94.11% | 101.19% | 56.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 96.95% | -100.40% | 101.19% | 56.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.43% | -5.80% | -228.89% | -- | -- |
| Issuance of Common Stock | -99.93% | 49,319.29% | -100.00% | -100.00% | 131,600.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.26% | 43,398.04% | 31,565.17% | 24,846.75% | 222,142.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -829.45% | 148.21% | -104.32% | 73.28% | 112.42% |